News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
764,307 Results
Type
Article (47718)
Company Profile (347)
Press Release (716219)
Multimedia
Podcasts (110)
Webinars (23)
Section
Business (213781)
Career Advice (2243)
Deals (37284)
Drug Delivery (147)
Drug Development (84905)
Employer Resources (179)
FDA (17250)
Job Trends (15853)
News (362412)
Policy (34617)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2781)
Accelerated approval (47)
Adcomms (30)
Allergies (176)
Alliances (52758)
ALS (208)
Alzheimer's disease (1844)
Antibody-drug conjugate (ADC) (459)
Approvals (17578)
Artificial intelligence (663)
Autoimmune disease (260)
Automation (54)
Bankruptcy (385)
Best Places to Work (12051)
BIOSECURE Act (22)
Biosimilars (220)
Biotechnology (234)
Bladder cancer (185)
Brain cancer (73)
Breast cancer (732)
Cancer (5791)
Cardiovascular disease (477)
Career advice (1905)
Career pathing (45)
CAR-T (331)
CDC (64)
Celiac Disease (2)
Cell therapy (878)
Cervical cancer (46)
Clinical research (73057)
Collaboration (2113)
Company closure (5)
Compensation (1341)
Complete response letters (85)
COVID-19 (2902)
CRISPR (109)
C-suite (1097)
Cystic fibrosis (155)
Data (7576)
Decentralized trials (3)
Denatured (29)
Depression (172)
Dermatology (71)
Diabetes (583)
Diagnostics (7215)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (47)
Drug discovery (322)
Drug pricing (213)
Drug shortages (32)
Duchenne muscular dystrophy (282)
Earnings (93014)
Editorial (70)
Employer branding (21)
Employer resources (158)
Events (124774)
Executive appointments (1101)
FDA (20887)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1736)
Gene editing (234)
Generative AI (63)
Gene therapy (726)
GLP-1 (1126)
Government (5016)
Grass and pollen (8)
Guidances (403)
Healthcare (19821)
HIV (79)
Huntington's disease (56)
IgA nephropathy (95)
Immunology and inflammation (309)
Immuno-oncology (93)
Indications (168)
Infectious disease (3252)
Inflammatory bowel disease (219)
Inflation Reduction Act (14)
Influenza (139)
Intellectual property (284)
Interviews (373)
IPO (17206)
IRA (51)
Job creations (4120)
Job search strategy (1578)
JPM (63)
Kidney cancer (19)
Labor market (98)
Layoffs (619)
Leadership (41)
Legal (8460)
Liver cancer (105)
Longevity (32)
Lung cancer (772)
Lymphoma (425)
Machine learning (58)
Management (61)
Manufacturing (1022)
MASH (186)
Medical device (14372)
Medtech (14462)
Mergers & acquisitions (21284)
Metabolic disorders (1523)
mRNA (218)
Multiple sclerosis (187)
NASH (24)
Neurodegenerative disease (416)
Neuropsychiatric disorders (108)
Neuroscience (3372)
Neurotech (1)
NextGen: Class of 2026 (6980)
Non-profit (4749)
Now hiring (75)
Obesity (726)
Opinion (320)
Ovarian cancer (212)
Pain (250)
Pancreatic cancer (287)
Parkinson's disease (368)
Partnered (34)
Patents (578)
Patient recruitment (647)
Peanut (64)
People (62331)
Pharmaceutical (70)
Pharmacy benefit managers (32)
Phase 1 (22835)
Phase 2 (32151)
Phase 3 (23944)
Pipeline (7814)
Policy (329)
Postmarket research (2654)
Preclinical (9765)
Press Release (71)
Prostate cancer (293)
Psychedelics (60)
Radiopharmaceuticals (332)
Rare diseases (1076)
Real estate (6461)
Recruiting (72)
Regulatory (26456)
Reports (57)
Research institute (2568)
Resumes & cover letters (377)
Rett syndrome (35)
RNA editing (20)
RSV (92)
Schizophrenia (179)
Series A (292)
Series B (217)
Service/supplier (12)
Sickle cell disease (115)
Special edition (26)
Spinal muscular atrophy (171)
Sponsored (50)
Startups (4019)
State (2)
Stomach cancer (20)
Supply chain (126)
Tariffs (90)
The Weekly (79)
Vaccines (1161)
Venture capital (109)
Weight loss (483)
Women's health (120)
Worklife (22)
Date
Today (2)
Last 7 days (781)
Last 30 days (2588)
Last 365 days (31288)
2026 (10202)
2025 (31295)
2024 (36508)
2023 (41453)
2022 (52680)
2021 (57276)
2020 (55901)
2019 (48778)
2018 (36874)
2017 (33929)
2016 (33604)
2015 (39627)
2014 (33197)
2013 (28242)
2012 (30379)
2011 (31026)
2010 (29026)
Location
Africa (834)
Alabama (96)
Alaska (7)
Arizona (352)
Arkansas (15)
Asia (42997)
Australia (7262)
California (12901)
Canada (3675)
China (1358)
Colorado (550)
Connecticut (554)
Delaware (388)
Europe (95436)
Florida (1910)
Georgia (420)
Hawaii (3)
Idaho (63)
Illinois (1060)
India (89)
Indiana (587)
Iowa (24)
Japan (520)
Kansas (136)
Kentucky (49)
Louisiana (42)
Maine (75)
Maryland (1558)
Massachusetts (9287)
Michigan (353)
Minnesota (704)
Mississippi (6)
Missouri (147)
Montana (36)
Nebraska (29)
Nevada (141)
New Hampshire (88)
New Jersey (3426)
New Mexico (31)
New York (3408)
North Carolina (1667)
North Dakota (9)
Northern California (6408)
Ohio (387)
Oklahoma (25)
Oregon (42)
Pennsylvania (2591)
Puerto Rico (28)
Rhode Island (50)
South America (1230)
South Carolina (86)
South Dakota (2)
Southern California (5064)
Tennessee (205)
Texas (2057)
United States (45835)
Utah (387)
Vermont (1)
Virginia (318)
Washington D.C. (82)
Washington State (1048)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
764,307 Results for "base pair biotechnologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ELEPHAS BIOSCIENCES AND MITHRL PAIR REAL-TIME TUMOR PROFILING WITH AGENTIC AI TO UNLOCK NEW IMMUNOTHERAPY RESPONSE INSIGHTS
April 17, 2026
·
3 min read
Press Releases
Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites
February 17, 2026
·
2 min read
Press Releases
ONWARD Medical Completes Two Additional Brain-Computer Interface Implants Paired with Spinal Cord Stimulation Technology to Restore Thought-Driven Movement
January 22, 2026
·
6 min read
Funding
Novartis-backed Sidewinder collects $137M series B to strike at difficult-to-treat tumors
Sidewinder Therapeutics’ bispecific antibody-drug conjugates target pairs of receptors found on cancer cells, which the company claims improves their specificity and minimizes off-target effects.
April 9, 2026
·
2 min read
·
Tristan Manalac
Funding
Backed by Sanofi, Pfizer, Earendil Bags $787M for AI-Driven Biologics Design
Earendil Labs’ AI-centered platform has produced more than 40 programs, including anti-inflammatory assets that have attracted a pair of partnership agreements with Sanofi.
March 23, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Lightship Inc. Acquires Veda Trials to Expand Community-Based Clinical Research Delivery
The acquisition expands scalable trial operations across real-world care settings
February 4, 2026
·
1 min read
Press Releases
Lightship Inc. Acquires Veda Trials to Expand Community-Based Clinical Research Delivery
February 5, 2026
·
3 min read
Press Releases
OBI Pharma Announces Ten Poster Presentations at the AACR 2026 Annual Meeting for GlycOBI(R) Glycan-based Site-Specific Antibody-Drug Conjugates (ADCs): Mono and Bi-Specific (inc. Dual payload) and Obrion(TM) ADC enabling technologies
April 15, 2026
·
16 min read
Press Releases
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results
April 8, 2026
·
5 min read
Press Releases
Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit
April 7, 2026
·
5 min read
1 of 76,431
Next
